Proteome and computational analyses reveal new insights into the mechanisms of hepatitis C virus-mediated liver disease posttransplantation

Hepatology

Volumn 56, Issue 1, 2012, Pages 28-38

  Diamond, Deborah L ^a   Krasnoselsky, Alexei L ^a   Burnum, Kristin E ^b   Monroe, Matthew E ^b   Webb Robertson, Bobbie Jo ^b   Mcdermott, Jason E ^b   Yeh, Matthew M ^a   Dzib, Jose Felipe Golib ^c   Susnow, Nathan ^a,e   Strom, Susan ^a   Proll, Sean C ^a   Belisle, Sarah E ^a   Purdy, David E ^a   Rasmussen, Angela L ^a   Walters, Kathie Anne ^a,f   Jacobs, Jon M ^b   Gritsenko, Marina A ^b   Camp, David G ^b   Bhattacharya, Renuka ^a   Perkins, James D ^a   Carithers, Robert L ^a   Liou, Iris W ^c   Larson, Anne M ^a,g   Benecke, Arndt ^c   Waters, Katrina M ^b   Smith, Richard D ^b   Katze, Michael G ^a,d   more..

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^c CNRS   (France)

^d UNIVERSITY OF WASHINGTON   (United States)

^e Meriter Medical Group   (United States)

^f INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^g Swedish Liver Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TROPOMYOSIN; ANGIOTENSINOGEN; CARBONATE DEHYDRATASE II; CARBONATE DEHYDRATASE IV; CATHEPSIN X; CHLORIDE CHANNEL; CLATHRIN; CONNECTIVE TISSUE GROWTH FACTOR; CYCLIN DEPENDENT KINASE 2; CYSTATHIONINE BETA SYNTHASE; CYTOCHROME B; DEOXYRIBONUCLEASE II; DIMETHYLANILINE MONOOXYGENASE; FILAMIN; GALECTIN 3; GLUTATHIONE TRANSFERASE ALPHA; GUANINE NUCLEOTIDE BINDING PROTEIN; HEAT SHOCK PROTEIN 10; HEAT SHOCK PROTEIN 70; HEMOPEXIN; HERMES ANTIGEN; LEUKOTRIENE A4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYOSIN; NUCLEAR RECEPTOR COACTIVATOR 2; PROTEIN BAX; PROTEIN BCL 10; PROTEIN DNAJ; PROTEOME; UNINDEXED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROGENESIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNITY; LIVER BIOPSY; LIVER DISEASE; LIVER FIBROSIS; LIVER INJURY; LIVER PROTECTION; LIVER TRANSPLANTATION; MALE; MODEL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; RECEIVER OPERATING CHARACTERISTIC;

ADULT; AGED; BIOPSY, NEEDLE; CHROMATOGRAPHY, LIQUID; COHORT STUDIES; DIAGNOSIS, COMPUTER-ASSISTED; DISEASE PROGRESSION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MASS SPECTROMETRY; MIDDLE AGED; OXIDATIVE STRESS; PROTEIN ARRAY ANALYSIS; PROTEOME; PROTEOMICS; RECURRENCE; REFERENCE VALUES; RISK ASSESSMENT; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84863534126     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25649     Document Type: Article

References (43)

1. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 1992; 327: 1899-1905.
2. Kim WR. The burden of hepatitis C in the United States. HEPATOLOGY 2002; 36: S30-S34.
3. Diamond DL, Jacobs JM, Paeper B, Proll SC, Gritsenko MA, Carithers RL Jr, et al. Proteomic profiling of human liver biopsies: hepatitis C virus-induced fibrosis and mitochondrial dysfunction. HEPATOLOGY 2007; 46: 649-657.
4. Diamond DL, Proll SC, Jacobs JM, Chan EY, Camp DG 2nd, Smith RD, et al. HepatoProteomics: applying proteomic technologies to the study of liver function and disease. HEPATOLOGY 2006; 44: 299-308.
5. Jacobs JM, Diamond DL, Chan EY, Gritsenko MA, Qian W, Stastna M, et al. Proteome analysis of liver cells expressing a full-length hepatitis C virus (HCV) replicon and biopsy specimens of posttransplantation liver from HCV-infected patients. J Virol 2005; 79: 7558-7569.
6. Pezacki JP, Singaravelu R, Lyn RK. Host-virus interactions during hepatitis C virus infection: a complex and dynamic molecular biosystem. Mol Biosyst 2010; 6: 1131-1142.
7. Walters KA, Katze MG. Using high-throughput genomics to study hepatitis C: what determines the outcome of infection? Antiviral Res 2009; 81: 198-208.
8. Smith MW, Walters KA, Korth MJ, Fitzgibbon M, Proll S, Thompson JC, et al. Gene expression patterns that correlate with hepatitis C and early progression to fibrosis in liver transplant recipients. Gastroenterology 2006; 130: 179-187.
9. Rodriguez-Luna H, Douglas DD. Natural history of hepatitis C following liver transplantation. Curr Opin Infect Dis 2004; 17: 363-371.
10. Shuhart MC, Bronner MP, Gretch DR, Thomassen LV, Wartelle CF, Tateyama H, et al. Histological and clinical outcome after liver transplantation for hepatitis C. HEPATOLOGY 1997; 26: 1646-1652.
11. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995; 19: 1409-1417.
12. Diamond DL, Syder AJ, Jacobs JM, Sorensen CM, Walters KA, Proll SC, et al. Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics. PLoS Pathog 2010; 6: e1000719.
13. Webb-Robertson BJ, McCue LA, Waters KM, Matzke MM, Jacobs JM, Metz TO, et al. Combined statistical analyses of peptide intensities and peptide occurrences improves identification of significant peptides from MS-based proteomics data. J Proteome Res 2010; 9: 5748-5756.
14. Becavin C, Benecke A. New dimensionality reduction methods for the representation of high dimensional 'omics' data. Expert Rev Mol Diagn 2011; 11: 27-34.
15. Becavin C, Tchitchek N, Mintsa-Eya C, Lesne A, Benecke A. Improving the efficiency of multidimensional scaling in the analysis of high-dimensional data using singular value decomposition. Bioinformatics 2011; 27: 1413-1421.
16. Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem 2009; 81: 6656-6667.
17. Kalhan SC, Guo L, Edmison J, Dasarathy S, McCullough AJ, Hanson RW, et al. Plasma metabolomic profile in nonalcoholic fatty liver disease. Metabolism 2011; 60: 404-413.
18. Roe B, Kensicki E, Mohney R, Hall WW. Metabolomic profile of hepatitis C virus-infected hepatocytes. PLoS One 2011; 6: e23641.
19. Rasmussen AL, Diamond DL, McDermott JE, Gao X, Metz TO, Matzke MM, et al. Systems virology identifies a mitochondrial fatty acid oxidation enzyme, dodecenoyl coenzyme a delta isomerase, required for hepatitis C virus replication and likely pathogenesis. J Virol 2011; 85: 11646-11654.
20. Dyer MD, Murali TM, Sobral BW. The landscape of human proteins interacting with viruses and other pathogens. PLoS Pathog 2008; 4: e32.
21. McDermott JE, Taylor RC, Yoon H, Heffron F. Bottlenecks and hubs in inferred networks are important for virulence in Salmonella typhimurium. J Comput Biol 2009; 16: 169-180.
22. Yu H, Kim PM, Sprecher E, Trifonov V, Gerstein M. The importance of bottlenecks in protein networks: correlation with gene essentiality and expression dynamics. PLoS Comput Biol 2007; 3: e59.
23. Gehrau R, Maluf D, Archer K, Stravitz R, Suh J, Le N, et al. Molecular pathways differentiate hepatitis C virus (HCV) recurrence from acute cellular rejection in HCV liver recipients. Mol Med 2011; 17: 824-833.
24. Chaudhury A, Hussey GS, Ray PS, Jin G, Fox PL, Howe PH. TGF-beta-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEI. Nat Cell Biol 2010; 12: 286-293.
25. Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol 2011; 6: 425-456.
26. Thomson S, Petti F, Sujka-Kwok I, Mercado P, Bean J, Monaghan M, et al. A systems view of epithelial-mesenchymal transition signaling states. Clin Exp Metastasis 2011; 28: 137-155.
27. Auge N, Nikolova-Karakashian M, Carpentier S, Parthasarathy S, Negre-Salvayre A, Salvayre R, et al. Role of sphingosine 1-phosphate in the mitogenesis induced by oxidized low density lipoprotein in smooth muscle cells via activation of sphingomyelinase, ceramidase, and sphingosine kinase. J Biol Chem 1999; 274: 21533-21538.
28. Boers W, Aarrass S, Linthorst C, Pinzani M, Elferink RO, Bosma P. Transcriptional profiling reveals novel markers of liver fibrogenesis: gremlin and insulin-like growth factor-binding proteins. J Biol Chem 2006; 281: 16289-16295.
29. Karolczak-Bayatti M, Loughney AD, Robson SC, Europe-Finner GN. Epigenetic modulation of the protein kinase A RIIalpha (PRKAR2A) gene by histone deacetylases 1 and 2 in human smooth muscle cells. J Cell Mol Med 2011; 15: 94-108.
30. Liu M, Zhou L, Xu A, Lam KS, Wetzel MD, Xiang R, et al. A disulfide-bond A oxidoreductase-like protein (DsbA-L) regulates adiponectin multimerization. Proc Natl Acad Sci U S A 2008; 105: 18302-18307.
31. Moazed B, Banman SL, Wilkinson GA, Roesler WJ. TCERG1 inhibits C/EBPalpha through a mechanism that does not involve sequestration of C/EBPalpha at pericentromeric heterochromatin. J Cell Biochem 2011; 112: 2317-2326.
32. Molleken C, Sitek B, Henkel C, Poschmann G, Sipos B, Wiese S, et al. Detection of novel biomarkers of liver cirrhosis by proteomic analysis. HEPATOLOGY 2009; 49: 1257-1266.
33. Shu J, Kren BT, Xia Z, Wong PY, Li L, Hanse EA, et al. Genomewide microRNA down-regulation as a negative feedback mechanism in the early phases of liver regeneration. HEPATOLOGY 2011; 54: 609-619.
34. Spangberg K, Schwartz S. Poly(C)-binding protein interacts with the hepatitis C virus 5' untranslated region. J Gen Virol 1999; 80: 1371-1376.
35. Rasmussen AL, Tchitchek N, Susnow NJ, Krasnoselsky AL, Diamond DL, Yeh MM, et al. Early transcriptional programming links progression to hepatitis C virus-induced severe liver disease in transplant patients. Hepatology 2012; 56: 28-38.
36. Soga T, Sugimoto M, Honma M, Mori M, Igarashi K, Kashikura K, et al. Serum metabolomics reveals gamma-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease. J Hepatol 2011; 55: 896-905.
37. Robert K, Nehme J, Bourdon E, Pivert G, Friguet B, Delcayre C, et al. Cystathionine beta synthase deficiency promotes oxidative stress, fibrosis, and steatosis in mice liver. Gastroenterology 2005; 128: 1405-1415.
38. Soga T, Baran R, Suematsu M, Ueno Y, Ikeda S, Sakurakawa T, et al. Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption. J Biol Chem 2006; 281: 16768-16776.
39. Madill J, Arendt B, Aghdassi E, Chow C, Guindi M, Therapondos G, et al. Oxidative stress and nutritional factors in hepatitis C virus-positive liver recipients, controls, and hepatitis C virus-positive nontransplant patients. Transplant Proc 2010; 42: 1744-1749.
40. Miura K, Taura K, Kodama Y, Schnabl B, Brenner DA. Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity. HEPATOLOGY 2008; 48: 1420-1429.
41. Niki T, Rombouts K, De Bleser P, De Smet K, Rogiers V, Schuppan D, et al. A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture. HEPATOLOGY 1999; 29: 858-867.
42. Britton LM, Gonzales-Cope M, Zee BM, Garcia BA. Breaking the histone code with quantitative mass spectrometry. Expert Rev Proteomics 2011; 8: 631-643.
43. Washburn ML, Bility MT, Zhang L, Kovalev GI, Buntzman A, Frelinger JA, et al. A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease. Gastroenterology 2011; 140: 1334-1344.